spacer
spacer
Go to PDB code: 
protein ligands Protein-protein interface(s) links
Growth factor/growth factor receptor PDB-id
1cvs
Biological unit* = asymmetric unit, as shown
(*as deduced by PQS)
Main view
    Jmol     Help!  
Contents
Description
Header details
Header records
References
PROCHECK
Protein chains
129 a.a. *
211 a.a. *
196 a.a. *
Ligands
SO4 ×4

* Residue conservation analysis
Tools
Image Generation
AstexViewer™@PDBe
Run PROCHECK
Clefts Calculation
  
Bottom view Right view
PDB id: 1cvs
Name: Growth factor/growth factor receptor
Title: Crystal structure of a dimeric fgf2-fgfr1 complex

Structure:
Fibroblast growth factor 2. Chain: a, b. Engineered: yes. Mutation: yes. Fibroblast growth factor receptor 1. Chain: c, d. Fragment: ig-like domains 2 and 3. Engineered: yes. Mutation: yes

Source:
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562. Expression_system_taxid: 562

Biological unit:
Tetramer (from PQS)

UniProt:
Chains A, B: P09038 (FGF2_HUMAN)
Pfam  
Seq: 210 a.a.
Struc: 129 a.a.*

Chain C: P11362 (FGFR1_HUMAN)
Pfam  
Seq:
Struc:
Seq:
Struc:
Seq:
Struc:
Seq: 822 a.a.
Struc: 211 a.a.*

Chain D: P11362 (FGFR1_HUMAN)
Pfam  
Seq:
Struc:
Seq:
Struc:
Seq:
Struc:
Seq: 822 a.a.
Struc: 196 a.a.*
Key:    PfamA domain
 Secondary structure  CATH domain
* PDB and UniProt seqs differ at 4 residue positions (black crosses)

Enzyme class:
Chains C, D: E.C.2.7.10.1   [IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

Reaction:
ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate

Resolution:
2.80Å

R-factor:
0.240

R-free:
0.281

Authors:
A.N.Plotnikov,J.Schlessinger,S.R.Hubbard,M.Mohammadi

Key ref:
A.N.Plotnikov et al. (1999). Structural basis for FGF receptor dimerization and activation.. Cell, 98, 641-650. [PubMed id: 10490103] [DOI: 10.1016/S0092-8674(00)80051-3]

Date:
24-Aug-99

Release date:
28-Jan-00
Quick_links
RCSB
PDBe
SRS
MMDB
JenaLib
OCA
Proteopedia
CATH
SCOP
FSSP
HSSP
PDBSWS
PQS
ProSAT
Whatcheck
Procheck
Go to PROCHECK summary
Surface
RasMol surface
spacer
spacer

 
    Key reference    
 
 
DOI no: 10.1016/S0092-8674(00)80051-3 Cell 98:641-650 (1999)
PubMed id: 10490103  
 
 
Structural basis for FGF receptor dimerization and activation.
A.N.Plotnikov, J.Schlessinger, S.R.Hubbard, M.Mohammadi.
 
  ABSTRACT  
 
The crystal structure of FGF2 bound to a naturally occurring variant of FGF receptor 1 (FGFR1) consisting of immunoglobulin-like domains 2 (D2) and 3 (D3) has been determined at 2.8 A resolution. Two FGF2:FGFR1 complexes form a 2-fold symmetric dimer. Within each complex, FGF2 interacts extensively with D2 and D3 as well as with the linker between the two domains. The dimer is stabilized by interactions between FGF2 and D2 of the adjoining complex and by a direct interaction between D2 of each receptor. A positively charged canyon formed by a cluster of exposed basic residues likely represents the heparin-binding site. A general model for FGF- and heparin-induced FGFR dimerization is inferred from the crystal structure, unifying a wealth of biochemical data.
 
  Selected figure(s)  
 
Figure 4.
Figure 4. Mapping of the Different Interaction Sites onto the Molecular Surfaces of FGF2 and FGFR1The surface color codings for D2, D3, the linker, and FGF2 are the same as in Figure 1. The surfaces of FGF2 and FGFR1 that form the primary and secondary interaction sites are shown in red and purple, respectively. The heparin-binding surfaces are depicted in blue. The surface on D2 engaged in direct receptor–receptor interaction is colored yellow. To better visualize the different functional surfaces on FGF2 and D23, the two molecules are pulled away from each other and rotated 90° about the vertical axis. This figure was created using the program GRASP ( [33]).
Figure 5.
Figure 5. The Primary Interaction Site between FGF2 and FGFR1(A) Stereo view of the hydrophobic interface between FGF2 and D2 of FGFR1. Only side chains of interacting residues are shown. Color coding is the same as in Figure 1: FGF2 in orange, D2 in green, D3 in blue, and the linker in gray. Dotted lines represent hydrogen bonds.(B) Stereo view of the network of hydrogen bonds between FGF2 and FGFR1 in the vicinity of Arg-250 in the D2–D3 linker.(C) Stereo view of the interface between FGF2 and D3 of FGFR1. This figure was created using the programs Molscript and Raster3D.
 
  The above figures are reprinted by permission from Cell Press: Cell (1999, 98, 641-650) copyright 1999.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
19658168 E.Stuttfeld, and K.Ballmer-Hofer (2009).
Structure and function of VEGF receptors.
  IUBMB Life, 61, 915-922.  
19756300 J.Dengjel, I.Kratchmarova, and B.Blagoev (2009).
Receptor tyrosine kinase signaling: a view from quantitative proteomics.
  Mol Biosyst, 5, 1112-1121.  
19381019 J.Qing, X.Du, Y.Chen, P.Chan, H.Li, P.Wu, S.Marsters, S.Stawicki, J.Tien, K.Totpal, S.Ross, S.Stinson, D.Dornan, D.French, Q.R.Wang, J.P.Stephan, Y.Wu, C.Wiesmann, and A.Ashkenazi (2009).
Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice.
  J Clin Invest, 119, 1216-1229.
PDB code: 3grw
18773495 M.K.Hajihosseini, R.Duarte, J.Pegrum, A.Donjacour, E.Lana-Elola, D.P.Rice, J.Sharpe, and C.Dickson (2009).
Evidence that Fgf10 contributes to the skeletal and visceral defects of an apert syndrome mouse model.
  Dev Dyn, 238, 376-385.  
19053057 M.R.Bryant, C.B.Marta, F.S.Kim, and R.Bansal (2009).
Phosphorylation and lipid raft association of fibroblast growth factor receptor-2 in oligodendrocytes.
  Glia, 57, 935-946.  
19634127 S.Li, C.Christensen, L.B.Køhler, V.V.Kiselyov, V.Berezin, and E.Bock (2009).
Agonists of fibroblast growth factor receptor induce neurite outgrowth and survival of cerebellar granule neurons.
  Dev Neurobiol, 69, 837-854.  
19422094 Y.Hadari, and J.Schlessinger (2009).
FGFR3-targeted mAb therapy for bladder cancer and multiple myeloma.
  J Clin Invest, 119, 1077-1079.  
18493663 A.Kaushansky, A.Gordus, B.Chang, J.Rush, and G.MacBeath (2008).
A quantitative study of the recruitment potential of all intracellular tyrosine residues on EGFR, FGFR1 and IGF1R.
  Mol Biosyst, 4, 643-653.  
18593816 A.Kochoyan, F.M.Poulsen, V.Berezin, E.Bock, and V.V.Kiselyov (2008).
Structural basis for the activation of FGFR by NCAM.
  Protein Sci, 17, 1698-1705.  
18186042 B.A.Kwiatkowski, I.Kirillova, R.E.Richard, D.Israeli, and Z.Yablonka-Reuveni (2008).
FGFR4 and its novel splice form in myogenic cells: Interplay of glycosylation and tyrosine phosphorylation.
  J Cell Physiol, 215, 803-817.  
18177485 I.Matsumura, M.Mizuki, and Y.Kanakura (2008).
Roles for deregulated receptor tyrosine kinases and their downstream signaling molecules in hematologic malignancies.
  Cancer Sci, 99, 479-485.  
18310252 P.Sharma, D.Rajalingam, T.K.Kumar, and S.Singh (2008).
A light scattering study of the interaction of fibroblast growth factor (FGF) with its receptor.
  Biophys J, 94, L71-L73.  
17705152 S.B.Joshi, T.J.Kamerzell, C.McNown, and C.R.Middaugh (2008).
The interaction of heparin/polyanions with bovine, porcine, and human growth hormone.
  J Pharm Sci, 97, 1368-1385.  
18667431 S.Nadanaka, M.Ishida, M.Ikegami, and H.Kitagawa (2008).
Chondroitin 4-O-Sulfotransferase-1 Modulates Wnt-3a Signaling through Control of E Disaccharide Expression of Chondroitin Sulfate.
  J Biol Chem, 283, 27333-27343.  
18669637 W.Zhang, Y.Chen, M.R.Swift, E.Tassi, D.C.Stylianou, K.A.Gibby, A.T.Riegel, and A.Wellstein (2008).
Effect of FGF-binding Protein 3 on Vascular Permeability.
  J Biol Chem, 283, 28329-28337.  
17627937 B.C.Lin, M.Wang, C.Blackmore, and L.R.Desnoyers (2007).
Liver-specific activities of FGF19 require Klotho beta.
  J Biol Chem, 282, 27277-27284.  
17673524 R.S.Ashton, J.Peltier, C.A.Fasano, A.O'Neill, J.Leonard, S.Temple, D.V.Schaffer, and R.S.Kane (2007).
High-throughput screening of gene function in stem cells using clonal microarrays.
  Stem Cells, 25, 2928-2935.  
17525467 T.J.Kamerzell, S.B.Joshi, D.McClean, L.Peplinskie, K.Toney, D.Papac, M.Li, and C.R.Middaugh (2007).
Parathyroid hormone is a heparin/polyanion binding protein: binding energetics and structure modification.
  Protein Sci, 16, 1193-1203.  
17005551 E.Sanchez-Heras, F.V.Howell, G.Williams, and P.Doherty (2006).
The fibroblast growth factor receptor acid box is essential for interactions with N-cadherin and all of the major isoforms of neural cell adhesion molecule.
  J Biol Chem, 281, 35208-35216.  
16355117 M.Stevenson, E.Boos, C.Herbert, A.Hale, N.Green, M.Lyons, L.Chandler, K.Ulbrich, N.van Rooijen, V.Mautner, K.Fisher, and L.Seymour (2006).
Chick embryo lethal orphan virus can be polymer-coated and retargeted to infect mammalian cells.
  Gene Ther, 13, 356-368.  
16478533 N.Tang, M.He, M.A.O'Riordan, C.Farkas, K.Buck, V.Lemmon, and C.F.Bearer (2006).
Ethanol inhibits L1 cell adhesion molecule activation of mitogen-activated protein kinases.
  J Neurochem, 96, 1480-1490.  
16496021 P.Aloy, and R.B.Russell (2006).
Structural systems biology: modelling protein interactions.
  Nat Rev Mol Cell Biol, 7, 188-197.  
16834555 R.Sasisekharan, R.Raman, and V.Prabhakar (2006).
Glycomics approach to structure-function relationships of glycosaminoglycans.
  Annu Rev Biomed Eng, 8, 181-231.  
16384934 S.K.Olsen, J.Y.Li, C.Bromleigh, A.V.Eliseenkova, O.A.Ibrahimi, Z.Lao, F.Zhang, R.J.Linhardt, A.L.Joyner, and M.Mohammadi (2006).
Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain.
  Genes Dev, 20, 185-198.
PDB code: 2fdb
17132737 V.P.Eswarakumar, F.Ozcan, E.D.Lew, J.H.Bae, F.Tomé, C.J.Booth, D.J.Adams, I.Lax, and J.Schlessinger (2006).
Attenuation of signaling pathways stimulated by pathologically activated FGF-receptor 2 mutants prevents craniosynostosis.
  Proc Natl Acad Sci U S A, 103, 18603-18608.  
17008716 V.V.Kiselyov, A.Kochoyan, F.M.Poulsen, E.Bock, and V.Berezin (2006).
Elucidation of the mechanism of the regulatory function of the Ig1 module of the fibroblast growth factor receptor 1.
  Protein Sci, 15, 2318-2322.  
16731982 V.V.Kiselyov, E.Bock, V.Berezin, and F.M.Poulsen (2006).
NMR structure of the first Ig module of mouse FGFR1.
  Protein Sci, 15, 1512-1515.
PDB code: 2ckn
16135080 A.A.Anderson, C.E.Kendal, M.Garcia-Maya, A.V.Kenny, S.A.Morris-Triggs, T.Wu, R.Reynolds, E.Hohenester, and J.L.Saffell (2005).
A peptide from the first fibronectin domain of NCAM acts as an inverse agonist and stimulates FGF receptor activation, neurite outgrowth and survival.
  J Neurochem, 95, 570-583.  
16035076 C.Melendez-Vasquez, D.J.Carey, G.Zanazzi, O.Reizes, P.Maurel, and J.L.Salzer (2005).
Differential expression of proteoglycans at central and peripheral nodes of Ranvier.
  Glia, 52, 301-308.  
15806140 K.McDonnell, E.T.Bowden, R.Cabal-Manzano, B.Hoxter, A.T.Riegel, and A.Wellstein (2005).
Vascular leakage in chick embryos after expression of a secreted binding protein for fibroblast growth factors.
  Lab Invest, 85, 747-755.  
15632068 O.A.Ibrahimi, B.K.Yeh, A.V.Eliseenkova, F.Zhang, S.K.Olsen, M.Igarashi, S.A.Aaronson, R.J.Linhardt, and M.Mohammadi (2005).
Analysis of mutations in fibroblast growth factor (FGF) and a pathogenic mutation in FGF receptor (FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization.
  Mol Cell Biol, 25, 671-684.  
15924284 Q.Wu, J.Wang, L.Zhang, A.Hong, and J.Ren (2005).
Molecular recognition of basic fibroblast growth factor by polyoxometalates.
  Angew Chem Int Ed Engl, 44, 4048-4052.  
16045455 V.V.Kiselyov, V.Soroka, V.Berezin, and E.Bock (2005).
Structural biology of NCAM homophilic binding and activation of FGFR.
  J Neurochem, 94, 1169-1179.  
15905187 W.Zhang, R.Swanson, G.Izaguirre, Y.Xiong, L.F.Lau, and S.T.Olson (2005).
The heparin-binding site of antithrombin is crucial for antiangiogenic activity.
  Blood, 106, 1621-1628.  
15674480 B.Kaur, C.Tan, D.J.Brat, D.E.Post, and E.G.Van Meir (2004).
Genetic and hypoxic regulation of angiogenesis in gliomas.
  J Neurooncol, 70, 229-243.  
15365636 C.Dodé, and J.P.Hardelin (2004).
Kallmann syndrome: fibroblast growth factor signaling insufficiency?
  J Mol Med, 82, 725-734.  
14623883 C.Heiring, B.Dahlbäck, and Y.A.Muller (2004).
Ligand recognition and homophilic interactions in Tyro3: structural insights into the Axl/Tyro3 receptor tyrosine kinase family.
  J Biol Chem, 279, 6952-6958.
PDB code: 1rhf
14997572 E.Krieger, E.Geretti, B.Brandner, B.Goger, T.N.Wells, and A.J.Kungl (2004).
A structural and dynamic model for the interaction of interleukin-8 and glycosaminoglycans: support from isothermal fluorescence titrations.
  Proteins, 54, 768-775.  
15382229 M.J.Bernett, T.Somasundaram, and M.Blaber (2004).
An atomic resolution structure for human fibroblast growth factor 1.
  Proteins, 57, 626-634.
PDB code: 1rg8
14993768 N.Numao, H.Fujii, Y.Fukazawa, N.Hanagata, and K.Tanaka (2004).
Hydrophobic scale: a second parameter to elucidating various specific ligand-protein interactions.
  Chem Pharm Bull (Tokyo), 52, 377-379.  
15292251 P.M.Lievens, C.Mutinelli, D.Baynes, and E.Liboi (2004).
The kinase activity of fibroblast growth factor receptor 3 with activation loop mutations affects receptor trafficking and signaling.
  J Biol Chem, 279, 43254-43260.  
14718570 R.Islam, L.V.Kristiansen, S.Romani, L.Garcia-Alonso, and M.Hortsch (2004).
Activation of EGF receptor kinase by L1-mediated homophilic cell interactions.
  Mol Biol Cell, 15, 2003-2012.  
14732692 S.K.Olsen, O.A.Ibrahimi, A.Raucci, F.Zhang, A.V.Eliseenkova, A.Yayon, C.Basilico, R.J.Linhardt, J.Schlessinger, and M.Mohammadi (2004).
Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity.
  Proc Natl Acad Sci U S A, 101, 935-940.
PDB code: 1ry7
12496262 A.Facchiano, K.Russo, A.M.Facchiano, F.De Marchis, F.Facchiano, D.Ribatti, M.S.Aguzzi, and M.C.Capogrossi (2003).
Identification of a novel domain of fibroblast growth factor 2 controlling its angiogenic properties.
  J Biol Chem, 278, 8751-8760.  
12591959 B.K.Yeh, M.Igarashi, A.V.Eliseenkova, A.N.Plotnikov, I.Sher, D.Ron, S.A.Aaronson, and M.Mohammadi (2003).
Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors.
  Proc Natl Acad Sci U S A, 100, 2266-2271.
PDB code: 1nun
12627230 C.Dodé, J.Levilliers, J.M.Dupont, A.De Paepe, N.Le Dû, N.Soussi-Yanicostas, R.S.Coimbra, S.Delmaghani, S.Compain-Nouaille, F.Baverel, C.Pêcheux, D.Le Tessier, C.Cruaud, M.Delpech, F.Speleman, S.Vermeulen, A.Amalfitano, Y.Bachelot, P.Bouchard, S.Cabrol, J.C.Carel, H.Delemarre-van de Waal, B.Goulet-Salmon, M.L.Kottler, O.Richard, F.Sanchez-Franco, R.Saura, J.Young, C.Petit, and J.P.Hardelin (2003).
Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome.
  Nat Genet, 33, 463-465.  
12569279 F.I.Staquicini, C.R.Moreira, F.D.Nascimento, I.L.Tersariol, H.B.Nader, C.P.Dietrich, and J.D.Lopes (2003).
Enzyme and integrin expression by high and low metastatic melanoma cell lines.
  Melanoma Res, 13, 11-18.  
12647309 J.M.Myers, G.G.Martins, J.Ostrowski, and M.K.Stachowiak (2003).
Nuclear trafficking of FGFR1: a role for the transmembrane domain.
  J Cell Biochem, 88, 1273-1291.  
14690452 K.D.Kent, and J.A.Bomser (2003).
Bovine pituitary extract provides remarkable protection against oxidative stress in human prostate epithelial cells.
  In Vitro Cell Dev Biol Anim, 39, 388-394.  
12949995 L.A.Kueltzo, and C.R.Middaugh (2003).
Nonclassical transport proteins and peptides: an alternative to classical macromolecule delivery systems.
  J Pharm Sci, 92, 1754-1772.  
12791136 M.P.Machner, S.Frese, W.D.Schubert, V.Orian-Rousseau, E.Gherardi, J.Wehland, H.H.Niemann, and D.W.Heinz (2003).
Aromatic amino acids at the surface of InlB are essential for host cell invasion by Listeria monocytogenes.
  Mol Microbiol, 48, 1525-1536.  
12845611 O.De Wever, and M.Mareel (2003).
Role of tissue stroma in cancer cell invasion.
  J Pathol, 200, 429-447.  
12811234 S.Ali, L.A.Hardy, and J.A.Kirby (2003).
Transplant immunobiology: a crucial role for heparan sulfate glycosaminoglycans?
  Transplantation, 75, 1773-1782.  
12815063 S.K.Olsen, M.Garbi, N.Zampieri, A.V.Eliseenkova, D.M.Ornitz, M.Goldfarb, and M.Mohammadi (2003).
Fibroblast growth factor (FGF) homologous factors share structural but not functional homology with FGFs.
  J Biol Chem, 278, 34226-34236.
PDB code: 1q1u
12566461 Y.Yang, M.Børset, J.K.Langford, and R.D.Sanderson (2003).
Heparan sulfate regulates targeting of syndecan-1 to a functional domain on the cell surface.
  J Biol Chem, 278, 12888-12893.  
12604602 Z.L.Wu, L.Zhang, T.Yabe, B.Kuberan, D.L.Beeler, A.Love, and R.D.Rosenberg (2003).
The involvement of heparan sulfate (HS) in FGF1/HS/FGFR1 signaling complex.
  J Biol Chem, 278, 17121-17129.  
12205097 A.I.Arunkumar, S.Srisailam, T.K.Kumar, K.M.Kathir, Y.H.Chi, H.M.Wang, G.G.Chang, I.Chiu, and C.Yu (2002).
Structure and stability of an acidic fibroblast growth factor from Notophthalmus viridescens.
  J Biol Chem, 277, 46424-46432.
PDB code: 1fmm
12357470 A.O.Wilkie, S.J.Patey, S.H.Kan, A.M.van den Ouweland, and B.C.Hamel (2002).
FGFs, their receptors, and human limb malformations: clinical and molecular correlations.
  Am J Med Genet, 112, 266-278.  
11865065 A.R.Aricescu, I.W.McKinnell, W.Halfter, and A.W.Stoker (2002).
Heparan sulfate proteoglycans are ligands for receptor protein tyrosine phosphatase sigma.
  Mol Cell Biol, 22, 1881-1892.  
12203732 A.Voigt, R.Pflanz, U.Schäfer, and H.Jäckle (2002).
Perlecan participates in proliferation activation of quiescent Drosophila neuroblasts.
  Dev Dyn, 224, 403-412.  
12242295 B.K.Yeh, A.V.Eliseenkova, A.N.Plotnikov, D.Green, J.Pinnell, T.Polat, A.Gritli-Linde, R.J.Linhardt, and M.Mohammadi (2002).
Structural basis for activation of fibroblast growth factor signaling by sucrose octasulfate.
  Mol Cell Biol, 22, 7184-7192.  
12077148 B.M.Loo, and M.Salmivirta (2002).
Heparin/Heparan sulfate domains in binding and signaling of fibroblast growth factor 8b.
  J Biol Chem, 277, 32616-32623.  
11912193 C.Rolny, D.Spillmann, U.Lindahl, and L.Claesson-Welsh (2002).
Heparin amplifies platelet-derived growth factor (PDGF)- BB-induced PDGF alpha -receptor but not PDGF beta -receptor tyrosine phosphorylation in heparan sulfate-deficient cells. Effects on signal transduction and biological responses.
  J Biol Chem, 277, 19315-19321.  
12045103 J.D.Esko, and S.B.Selleck (2002).
Order out of chaos: assembly of ligand binding sites in heparan sulfate.
  Annu Rev Biochem, 71, 435-471.  
12167228 J.U.Park, and T.Tsuchiya (2002).
Increase in gap junctional intercellular communication by high molecular weight hyaluronic acid associated with fibroblast growth factor 2 and keratinocyte growth factor production in normal human dermal fibroblasts.
  Tissue Eng, 8, 419-427.  
11964230 M.Martin-Fernandez, D.T.Clarke, M.J.Tobin, S.V.Jones, and G.R.Jones (2002).
Preformed oligomeric epidermal growth factor receptors undergo an ectodomain structure change during signaling.
  Biophys J, 82, 2415-2427.  
11964252 M.Zamai, C.Hariharan, D.Pines, M.Safran, A.Yayon, V.R.Caiolfa, R.Cohen-Luria, E.Pines, and A.H.Parola (2002).
Nature of Interaction between basic fibroblast growth factor and the antiangiogenic drug 7,7-(carbonyl-bis[imino-N-methyl-4,2-pyrrolecarbonylimino[N-methyl-4,2-pyrrole]-carbonylimino])-bis-(1,3-naphtalene disulfonate). II. Removal of polar interactions affects protein folding.
  Biophys J, 82, 2652-2664.  
11972061 P.Aloy, and R.B.Russell (2002).
Interrogating protein interaction networks through structural biology.
  Proc Natl Acad Sci U S A, 99, 5896-5901.  
11781872 S.H.Kan, N.Elanko, D.Johnson, L.Cornejo-Roldan, J.Cook, E.W.Reich, S.Tomkins, A.Verloes, S.R.Twigg, S.Rannan-Eliya, D.M.McDonald-McGinn, E.H.Zackai, S.A.Wall, M.Muenke, and A.O.Wilkie (2002).
Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis.
  Am J Hum Genet, 70, 472-486.  
12218057 T.Sasaki, P.G.Knyazev, Y.Cheburkin, W.Göhring, D.Tisi, A.Ullrich, R.Timpl, and E.Hohenester (2002).
Crystal structure of a C-terminal fragment of growth arrest-specific protein Gas6. Receptor tyrosine kinase activation by laminin G-like domains.
  J Biol Chem, 277, 44164-44170.
PDB code: 1h30
12036964 V.M.Panin, L.Shao, L.Lei, D.J.Moloney, K.D.Irvine, and R.S.Haltiwanger (2002).
Notch ligands are substrates for protein O-fucosyltransferase-1 and Fringe.
  J Biol Chem, 277, 29945-29952.  
12464636 V.Orian-Rousseau, L.Chen, J.P.Sleeman, P.Herrlich, and H.Ponta (2002).
CD44 is required for two consecutive steps in HGF/c-Met signaling.
  Genes Dev, 16, 3074-3086.  
11520921 A.Liu, and A.L.Joyner (2001).
Early anterior/posterior patterning of the midbrain and cerebellum.
  Annu Rev Neurosci, 24, 869-896.  
11746231 C.Z.Borland, J.L.Schutzman, and M.J.Stern (2001).
Fibroblast growth factor signaling in Caenorhabditis elegans.
  Bioessays, 23, 1120-1130.  
  11276432 D.M.Ornitz, and N.Itoh (2001).
Fibroblast growth factors.
  Genome Biol, 2, REVIEWS3005.  
11571292 E.J.Williams, G.Williams, F.V.Howell, S.D.Skaper, F.S.Walsh, and P.Doherty (2001).
Identification of an N-cadherin motif that can interact with the fibroblast growth factor receptor and is required for axonal growth.
  J Biol Chem, 276, 43879-43886.  
11223514 H.J.Hecht, R.Adar, B.Hofmann, O.Bogin, H.Weich, and A.Yayon (2001).
Structure of fibroblast growth factor 9 shows a symmetric dimer with unique receptor- and heparin-binding interfaces.
  Acta Crystallogr D Biol Crystallogr, 57, 378-384.
PDB code: 1g82
11390973 O.A.Ibrahimi, A.V.Eliseenkova, A.N.Plotnikov, K.Yu, D.M.Ornitz, and M.Mohammadi (2001).
Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome.
  Proc Natl Acad Sci U S A, 98, 7182-7187.
PDB codes: 1ii4 1iil
11486033 P.Bellosta, A.Iwahori, A.N.Plotnikov, A.V.Eliseenkova, C.Basilico, and M.Mohammadi (2001).
Identification of receptor and heparin binding sites in fibroblast growth factor 4 by structure-based mutagenesis.
  Mol Cell Biol, 21, 5946-5957.
PDB code: 1ijt
11724555 S.Ye, Y.Luo, W.Lu, R.B.Jones, R.J.Linhardt, I.Capila, T.Toida, M.Kan, H.Pelletier, and W.L.McKeehan (2001).
Structural basis for interaction of FGF-1, FGF-2, and FGF-7 with different heparan sulfate motifs.
  Biochemistry, 40, 14429-14439.
PDB codes: 1qqk 1qql
11352941 X.Li, Y.Chen, S.Schéele, E.Arman, R.Haffner-Krausz, P.Ekblom, and P.Lonai (2001).
Fibroblast growth factor signaling and basement membrane assembly are connected during epithelial morphogenesis of the embryoid body.
  J Cell Biol, 153, 811-822.  
11257129 Y.V.Fedorov, R.S.Rosenthal, and B.B.Olwin (2001).
Oncogenic Ras-induced proliferation requires autocrine fibroblast growth factor 2 signaling in skeletal muscle cells.
  J Cell Biol, 152, 1301-1305.  
11551944 Z.Zhang, C.Coomans, and G.David (2001).
Membrane heparan sulfate proteoglycan-supported FGF2-FGFR1 signaling: evidence in support of the "cooperative end structures" model.
  J Biol Chem, 276, 41921-41929.  
11250709 C.Dickson, B.Spencer-Dene, C.Dillon, and V.Fantl (2000).
Tyrosine kinase signalling in breast cancer: fibroblast growth factors and their receptors.
  Breast Cancer Res, 2, 191-196.  
10618369 D.J.Stauber, A.D.DiGabriele, and W.A.Hendrickson (2000).
Structural interactions of fibroblast growth factor receptor with its ligands.
  Proc Natl Acad Sci U S A, 97, 49-54.
PDB code: 1djs
10655030 D.M.Ornitz (2000).
FGFs, heparan sulfate and FGFRs: complex interactions essential for development.
  Bioessays, 22, 108-112.  
11015187 F.P.Ottensmeyer, D.R.Beniac, R.Z.Luo, and C.C.Yip (2000).
Mechanism of transmembrane signaling: insulin binding and the insulin receptor.
  Biochemistry, 39, 12103-12112.  
10885578 I.McIntosh, G.A.Bellus, and E.W.Jab (2000).
The pleiotropic effects of fibroblast growth factor receptors in mammalian development.
  Cell Struct Funct, 25, 85-96.  
11121435 J.B.Kim, S.Islam, Y.J.Kim, R.S.Prudoff, K.M.Sass, M.J.Wheelock, and K.R.Johnson (2000).
N-Cadherin extracellular repeat 4 mediates epithelial to mesenchymal transition and increased motility.
  J Cell Biol, 151, 1193-1206.  
10913174 J.C.Arevalo, B.Conde, B.L.Hempstead, M.V.Chao, D.Martin-Zanca, and P.Perez (2000).
TrkA immunoglobulin-like ligand binding domains inhibit spontaneous activation of the receptor.
  Mol Cell Biol, 20, 5908-5916.  
11121055 K.Yu, A.B.Herr, G.Waksman, and D.M.Ornitz (2000).
Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome.
  Proc Natl Acad Sci U S A, 97, 14536-14541.  
10866805 K.Zou, H.Muramatsu, S.Ikematsu, S.Sakuma, R.H.Salama, T.Shinomura, K.Kimata, and T.Muramatsu (2000).
A heparin-binding growth factor, midkine, binds to a chondroitin sulfate proteoglycan, PG-M/versican.
  Eur J Biochem, 267, 4046-4053.  
10984527 M.A.Nugent (2000).
Heparin sequencing brings structure to the function of complex oligosaccharides.
  Proc Natl Acad Sci U S A, 97, 10301-10303.  
10819962 R.M.Lozano, A.Pineda-Lucena, C.Gonzalez, M.Angeles Jiménez, P.Cuevas, M.Redondo-Horcajo, J.M.Sanz, M.Rico, and G.Giménez-Gallego (2000).
1H NMR structural characterization of a nonmitogenic, vasodilatory, ischemia-protector and neuromodulatory acidic fibroblast growth factor.
  Biochemistry, 39, 4982-4993.
PDB codes: 1dzc 1dzd
10744718 S.Kumar, P.C.McDonnell, R.Lehr, L.Tierney, M.N.Tzimas, D.E.Griswold, E.A.Capper, R.Tal-Singer, G.I.Wells, M.L.Doyle, and P.R.Young (2000).
Identification and initial characterization of four novel members of the interleukin-1 family.
  J Biol Chem, 275, 10308-10314.  
10966463 S.R.Hubbard, and J.H.Till (2000).
Protein tyrosine kinase structure and function.
  Annu Rev Biochem, 69, 373-398.  
10880960 S.Yoshida, M.Shibata, S.Yamamoto, M.Hagihara, N.Asai, M.Takahashi, S.Mizutani, T.Muramatsu, and K.Kadomatsu (2000).
Homo-oligomer formation by basigin, an immunoglobulin superfamily member, via its N-terminal immunoglobulin domain.
  Eur J Biochem, 267, 4372-4380.  
11076027 T.L.Blundell, D.F.Burke, D.Chirgadze, V.Dhanaraj, M.Hyvönen, C.A.Innis, E.Parisini, L.Pellegrini, M.Sayed, and B.L.Sibanda (2000).
Protein-protein interactions in receptor activation and intracellular signalling.
  Biol Chem, 381, 955-959.  
10880433 X.Jiang, O.Gurel, E.A.Mendiaz, G.W.Stearns, C.L.Clogston, H.S.Lu, T.D.Osslund, R.S.Syed, K.E.Langley, and W.A.Hendrickson (2000).
Structure of the active core of human stem cell factor and analysis of binding to its receptor kit.
  EMBO J, 19, 3192-3203.
PDB code: 1scf
10884405 Z.Zhang, R.Zhang, A.Joachimiak, J.Schlessinger, and X.P.Kong (2000).
Crystal structure of human stem cell factor: implication for stem cell factor receptor dimerization and activation.
  Proc Natl Acad Sci U S A, 97, 7732-7737.
PDB code: 1exz
10574949 A.Chellaiah, W.Yuan, M.Chellaiah, and D.M.Ornitz (1999).
Mapping ligand binding domains in chimeric fibroblast growth factor receptor molecules. Multiple regions determine ligand binding specificity.
  J Biol Chem, 274, 34785-34794.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.